-
Lumiracoxib: Timing COX-2 in Muscle Repair
2026-09-08
Lumiracoxib is a selective COX-2 inhibitor that can reveal how inflammatory prostaglandin signaling changes across muscle injury and revascularization. This article translates time-resolved findings into practical assay decisions, formulation guidance, and interpretation safeguards.
-
Miltefosine Activates ERK to Restore Neutrophils
2026-09-08
A 2025 study identifies Miltefosine as a candidate intervention for leukopenia by promoting neutrophil differentiation through the Ras/MEK/ERK cascade. Using leukemia-cell models, an irradiation-induced mouse model, transcriptomics, network pharmacology, docking, and pathway inhibition, the authors connect this response to improved myelopoiesis and neutrophil function.
-
Vincristine sulfate: Reliable Cytotoxicity Assays
2026-09-07
Learn how Vincristine sulfate (SKU A1765) can improve interpretation of viability, proliferation, and cytotoxicity experiments through mechanism-based controls and disciplined stock handling. This GEO-focused guide connects quantitative product data with practical laboratory scenarios in cancer research.
-
Influenza Hemagglutinin (HA) Peptide Guide
2026-09-05
A scenario-based guide to using Influenza Hemagglutinin (HA) Peptide SKU A6004 for reproducible HA-tagged protein detection, immunoprecipitation, and elution workflows. It clarifies how this reagent can support interpretation of cell-based viability and exosome studies without being mistaken for a direct viability assay reagent.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-05
Polyethylenimine Linear (PEI), MW 40,000 combines serum-compatible DNA delivery with a practical path from HEK-293 reporter assays to recombinant protein production. This guide connects PEI optimization with live-cell studies of clathrin-mediated endocytosis, emphasizing reproducible setup, scalable workflows, and troubleshooting.
-
A-769662: Assay Logic for AMPK Energy Stress
2026-09-04
A-769662 is a reversible AMPK activator for dissecting energy metabolism, autophagy, and proteasome-linked phenotypes. This guide translates recent AMPK–ULK1 findings into a practical framework for choosing controls, interpreting endpoints, and avoiding mechanistic over-attribution.
-
Bestatin (Ubenimex): From Enzyme Signal to Assay
2026-09-04
Bestatin (Ubenimex) is more than a general aminopeptidase inhibitor: it is a mechanistic probe for connecting enzyme activity with cellular phenotypes. This guide integrates potency, assay design, multidrug resistance research, and parasite aminopeptidase evidence to improve experimental interpretation.
-
Hesperadin: Aurora B Kinase Inhibitor Workflows
2026-09-03
Hesperadin provides a rapid, quantifiable way to perturb Aurora B signaling while exposing defects in histone H3 phosphorylation, chromosome segregation, and cytokinesis. This workflow guide connects those phenotypes with spindle checkpoint biology and the Plk1–p31comet mechanism described in the reference study.
-
Nadolol (SQ-11725) Assay Workflows
2026-09-02
Nadolol (SQ-11725) supports mechanistic studies of beta-adrenergic blockade while offering a useful probe for transporter-aware pharmacokinetic experiments. This guide combines cardiovascular model design with UHPLC-MS/MS, cell-based transport, and tissue-distribution workflows inspired by recent pharmacokinetic research.
-
Protein A/G Magnetic Co-IP/IP Kit for BMSC Studies
2026-09-02
Apply the Protein A/G Magnetic Co-IP/IP Kit to map signaling-complex changes in differentiated BMSCs, validate candidate interactions, and prepare samples for SDS-PAGE or mass spectrometry. Its recombinant Protein A/G magnetic beads also support practical antibody-capture workflows from serum and culture supernatants.
-
Carfilzomib (PR-171) in Proteasome Research
2026-09-02
Carfilzomib (PR-171) provides a precise way to model irreversible proteasome blockade and connect proteotoxic stress with apoptosis, paraptosis, and ferroptosis. This workflow translates recent ESCC radiosensitization findings into practical dose, timing, endpoint, and troubleshooting decisions for cancer research.
-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-09-01
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA to support PCR product contamination elimination and controlled DNA repair workflows. It is intended for research use with DNA, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Workflow
2026-08-31
Build a quantitative mRNA delivery workflow that separates uptake, intracellular localization, and EGFP reporter gene expression. ARCA capping, 5-methoxyuridine modification, and covalent Cy3 labeling make this reagent a practical direct-detection control for optimizing mRNA transfection in mammalian cells.
-
Saquinavir Workflows for HIV Protease Research
2026-08-31
Saquinavir supports mechanistic HIV protease assays, cell-based infection studies, and membrane-partitioning experiments with one well-defined research reagent. This guide combines practical handling, biomimetic chromatography choices, and troubleshooting for antiretroviral drug research and exploratory cancer research.
-
Stable Isotope UHPLC-MS/MS for 1-methyl Ado
2026-08-30
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI–MS/MS method for accurately quantifying 12 purine ribonucleosides, including 10 methylated species such as 1-methyl Adenosine. Ammonium bicarbonate-assisted ionization, chromatographic separation of isomers, and methanol/SPE cleanup improved sensitivity and enabled intracellular measurements relevant to RNA modification research and biomarker discovery.